IN THIS ARTICLE
Cardiomyopathy is a prevalent disease. In the United States, up to a half million people develop a dilated cardiomyopathy every year. Ischemic cardiomyopathy may be present in up to 1% of the population. Because cardiomyopathy tends to be progressive, mortality depends upon the amount of heart pumping function loss; and one goal of therapy is to slow the rate of this loss.
Research on new medical and surgical treatments continues, ranging from new medications, stem cell research, and innovative types of implantable heart assist devices. Ongoing clinical trials for patients with cardiomyopathies are being conducted by the National Institutes of Health.
Must Read Articles Related to Cardiomyopathy